Abstract:OBJECTIVE Cavernous sinus hemangiomas (CSHs) are rare benign vascular tumors that arise from the dural venous sinuses lateral to the sella. Stereotactic radiosurgery (SRS) has emerged as a principal alternative to microresection for small-and medium-sized CSHs. Resection is a reasonable option for large (3-4 cm in diameter) and giant (> 4 cm in diameter) CSHs. However, management of giant CSHs remains a challenge for neurosurgeons because of the high rates of morbidity and even death that stem from uncontrollable and massive hemorrhage during surgery. The authors report here the results of their study on the use of hypofractionated SRS (H-SRS) to treat giant CSH. METHODS Between January 2008 and April 2014, 31 patients with a giant CSH (tumor volume > 40 cm(3), > 4 cm in diameter) treated using CyberKnife radiosurgery were enrolled in a cohort study. Clinical status and targeted reduction of tumor volume were evaluated by means of serial MRI. The diagnosis for 27 patients was determined on the basis of typical imaging features. In 4 patients, the diagnosis of CSH was confirmed histopathologically. The median CSH volume was 64.4 cm(3) (range 40.9-145.3 cm(3)). Three or 4 sessions of CyberKnife radiosurgery were used with a prescription dose based on the intent to cover the entire tumor with a higher dose while ensuring dose limitation to the visual pathways and brainstem. The median marginal dose to the tumor was 21 Gy (range 19.5-21 Gy) in 3 fractions for 11 patients and 22 Gy (range 18-22 Gy) in 4 fractions for 20 patients. RESULTS The median duration of follow-up was 30 months (range 6-78 months) for all patients. Follow-up MRI scans revealed a median tumor volume reduction of 88.1% (62.3%-99.4%) at last examination compared with the pretreatment volume. Ten patients developed new or aggravated temporary headache and 5 experienced vomiting during the treatment; these acute symptoms were relieved completely after steroid administration. Among the 30 patients with symptoms observed before treatment, 19 achieved complete symptomatic remission, and 11 had partial remission. One patient reported seizures, which were controlled after antiepileptic drug administration. No radiation-induced neurological deficits or delayed complications were reported during the follow-up period. CONCLUSIONS Hypofractionated SRS was an effective and safe modality for treating giant CSH. Considering the risks involved with microsurgery, it is possible that H-SRS might be able to serve as a definitive primary treatment option for giant CSH.

[Clinical Application of Radiotherapy for the Treatment of Giant Vascular Malformations in Oral and Maxillofacial Region].

Clinical Study of Mailgnant Brain Gliomas Treated by Interstitial Radiotherapy and Interstitial Chemotherapy

[The application of three dimensional craniomaxillofacial model in the restoration of mandibular bone defects with vascularized fibular autograft].

[Application of Three-Dimensional Tumor Mapping Technique in Diagnosis and Treatment of Malignant Maxillary Cancer].

Advances In Combination Of Antiangiogenic Agents Targeting Vegf-Binding And Conventional Chemotherapy And Radiation For Cancer Treatment

Fractionated Radiation Therapy for Large and Giant Cavernous Sinus Hemangioma: A Retrospective Study

[Radioactive Seed Implantation in Treatment of Oral and Maxillofacial Malignancy].

[Interventional Endovascular Therapeutic Modalities of Giant Intracranial Aneurysm].

Case Report: Clinical and Procedural Implications of Ommaya Reservoir Implantation in Cystic Brain Metastases Followed by Radiosurgery Treatment

Clinical Analysis of Multi-Disciplinary Team Management in the Treatment of Giant Neurofibroma in Maxillofa-Cial and Neck Region

Applicaltional Study of Absolute Ethanol Injection and Pingyangmycin Instrallation with Dynamic Intranidus Infusion to Treat Venous Malformation in Maxillofacial Region

[Synthetic Treatment of Malignant Tumor of Nasal Cavity and Sinus Based-on Modern Technique Radiotherapy].

Hypofractionated Stereotactic Radiosurgery: a New Treatment Strategy for Giant Cavernous Sinus Hemangiomas

Effect of radiofrequency ablation combined with DSA-guided percutaneous ethanol sclerotherapy for refractory arteriovenous malformations in oral and maxillofacial region

Application of Dental Applicator Treating Malignant Tumors Around Jaw

A Practical Guide for Diagnosis and Treatment of Arteriovenous Malformations in the Oral and Maxillofacial Region.

Application of Three-Dimensional Printing Technology in Oral and Maxillofacial Reconstruction

Radiotherapy Combined With Zoledronic Acid for Fibrous Dysplasia With a Central Giant Cell Granuloma: A Case Report

Surgical Treatment of Tumor Invading Vital Vessels

Clinical study of preoperative angiography and embolization of hypervascular neoplasms in the oral and maxillofacial region.

Giant vascular malformations invading the skull: A case report